Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Spinal Jaxx Interbody Fusion Device Recalled by Neuropro Spinal Jaxx Due to The implant size is incorrectly etched on the...

Date: January 18, 2018
Company: Neuropro Spinal Jaxx
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Neuropro Spinal Jaxx directly.

Affected Products

Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbody fusion device is indicated for spinal fusion for patients with degenerative disc disease (DDD) at one or two contiguous levels of the lumbosacral spine (L2-S1). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. Patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). The indicated patient population is skeletally mature patients who have had six (6) months of non-operative treatment. The Spinal Jaxx interbody fusion device must be used with autogenous bone graft material and with supplemental fixation.

Quantity: 6

Why Was This Recalled?

The implant size is incorrectly etched on the implant. The size listed on the box is correct.

Where Was This Sold?

The devices were distributed in California.

About Neuropro Spinal Jaxx

Neuropro Spinal Jaxx has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report